NO951122L - Anvendelse av hyaluronsyre for å forhindre arteriell restenose - Google Patents

Anvendelse av hyaluronsyre for å forhindre arteriell restenose

Info

Publication number
NO951122L
NO951122L NO951122A NO951122A NO951122L NO 951122 L NO951122 L NO 951122L NO 951122 A NO951122 A NO 951122A NO 951122 A NO951122 A NO 951122A NO 951122 L NO951122 L NO 951122L
Authority
NO
Norway
Prior art keywords
hyaluronic acid
arterial restenosis
prevent arterial
prevent
restenosis
Prior art date
Application number
NO951122A
Other languages
English (en)
Other versions
NO309457B1 (no
NO951122D0 (no
Inventor
Rudolf Edgar Falk
Samuel Simon Sculai
Eva Anne Turley
Original Assignee
Norpharmco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA1993/000388 external-priority patent/WO1994007505A1/en
Application filed by Norpharmco Inc filed Critical Norpharmco Inc
Publication of NO951122L publication Critical patent/NO951122L/no
Publication of NO951122D0 publication Critical patent/NO951122D0/no
Publication of NO309457B1 publication Critical patent/NO309457B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO951122A 1992-09-25 1995-03-23 Anvendelse av hyaluronsyre i fremstillingen av en farmasöytisk sammensetning for å forhindre arteriell restenose NO309457B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002079205A CA2079205C (en) 1992-09-25 1992-09-25 Use of hyaluronic acid and forms to prevent arterial restenosis
PCT/CA1993/000388 WO1994007505A1 (en) 1991-07-03 1993-09-22 Use of hyaluronic acid and forms to prevent arterial restenosis

Publications (3)

Publication Number Publication Date
NO951122L true NO951122L (no) 1995-03-23
NO951122D0 NO951122D0 (no) 1995-03-23
NO309457B1 NO309457B1 (no) 2001-02-05

Family

ID=4150463

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951122A NO309457B1 (no) 1992-09-25 1995-03-23 Anvendelse av hyaluronsyre i fremstillingen av en farmasöytisk sammensetning for å forhindre arteriell restenose

Country Status (26)

Country Link
EP (1) EP0661981B1 (no)
JP (1) JP3742955B2 (no)
CN (1) CN1057908C (no)
AP (1) AP448A (no)
AT (1) ATE141054T1 (no)
AU (1) AU670117B2 (no)
BR (1) BR9307221A (no)
CA (1) CA2079205C (no)
CZ (1) CZ288986B6 (no)
DE (1) DE69303931T2 (no)
DK (1) DK0661981T3 (no)
ES (1) ES2091031T3 (no)
GR (1) GR3021171T3 (no)
HK (1) HK35397A (no)
HU (2) HU227067B1 (no)
IL (1) IL107087A0 (no)
IN (1) IN181289B (no)
MD (1) MD960294A (no)
MX (1) MX9305887A (no)
NO (1) NO309457B1 (no)
NZ (1) NZ255978A (no)
PL (1) PL308201A1 (no)
SG (1) SG48845A1 (no)
SK (1) SK36895A3 (no)
TW (1) TW271401B (no)
ZA (1) ZA937068B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CN1101405C (zh) * 1997-08-22 2003-02-12 电气化学工业株式会社 透明质酸凝胶的制备方法、用此方法制得的透明质酸及包含这种凝胶的医用材料
FR2813791B1 (fr) 2000-09-14 2004-03-12 Lafon Labor Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease

Also Published As

Publication number Publication date
EP0661981B1 (en) 1996-08-07
CZ66295A3 (en) 1996-02-14
EP0661981A1 (en) 1995-07-12
HU211698A9 (en) 1995-12-28
MX9305887A (es) 1994-05-31
HK35397A (en) 1997-03-27
AP9300568A0 (en) 1993-10-31
CN1092654A (zh) 1994-09-28
CN1057908C (zh) 2000-11-01
ATE141054T1 (de) 1996-08-15
SG48845A1 (en) 1998-05-18
HU227067B1 (en) 2010-06-28
DE69303931D1 (de) 1996-09-12
CZ288986B6 (cs) 2001-10-17
NO309457B1 (no) 2001-02-05
AU670117B2 (en) 1996-07-04
DK0661981T3 (da) 1996-12-23
IN181289B (no) 1998-05-02
AP448A (en) 1996-01-18
CA2079205A1 (en) 1994-03-26
ZA937068B (en) 1994-04-18
ES2091031T3 (es) 1996-10-16
CA2079205C (en) 1998-02-10
TW271401B (no) 1996-03-01
BR9307221A (pt) 1999-07-27
HU9500857D0 (en) 1995-05-29
DE69303931T2 (de) 1997-01-09
PL308201A1 (en) 1995-07-24
NZ255978A (en) 1997-02-24
MD960294A (ro) 1997-10-31
JPH08506797A (ja) 1996-07-23
JP3742955B2 (ja) 2006-02-08
HUT73637A (en) 1996-08-28
NO951122D0 (no) 1995-03-23
SK36895A3 (en) 1997-03-05
AU4812693A (en) 1994-04-26
GR3021171T3 (en) 1996-12-31
IL107087A0 (en) 1993-12-28

Similar Documents

Publication Publication Date Title
FI943805L (fi) Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon
DE69330180D1 (de) Hyaluronsäure enthaltende formulierungen
FI942166A7 (fi) Menetelmiä restenoosin ehkäisemiseksi
IL103126A0 (en) 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents
AU6422294A (en) Use of hyaluronic acid and forms to prevent arterial restenosis
FI954007A0 (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
NO951122L (no) Anvendelse av hyaluronsyre for å forhindre arteriell restenose
ZA931489B (en) Use of interleuken-10 to suppress graft-vs-host disease
FI935168A7 (fi) 4-kloori-2-tiofeenikarboksyylihapon regioselektiivinen synteesi
FI943798L (fi) Kasvaimenvastaisen vaikutuksen lisäämiseen tarkoitettuja heterosyklisiä yhdisteitä
EP0467840A3 (en) Derivatives of cyclopropyle acetic acid
FI951377L (fi) N-asetyylineuramiinihappojohdannaisten synteesi
FI951378L (fi) N-asetyyli-neuramiinihapon johdannaisten synteesi
GB9517043D0 (en) The use of bile acid derivatives
FI925544A7 (fi) Bentsoehappojohdannaisia leukotrieeniin liittyvien sairauksien hoitami seen
NO940190L (no) Anvendelse av alpha-ketoglutarat
FI933300L (fi) Foerfarande foer rengoering av klorvaetesyra i gasform
FI954422L (fi) Ferroseenin käyttö
FI953106A7 (fi) Difuoripentapeptidijohdannaiset anti-inflammatorisina aineina
IT227994Y1 (it) Struttura di cinturino
ITMI921851A1 (it) Ammidi acriliche farmacologicamente attive
NO923728D0 (no) Regioselektiv syntese av 1,5-diarylpyrazol-antiinflammatoriske midler
AU7022496A (en) Use of hyaluronic acid and forms to prevent arterial restenosis
KR970003624U (ko) 처짐이 방지되는 모니터의 백커버

Legal Events

Date Code Title Description
MK1K Patent expired